| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |
From the Pathology Division, National Cancer Center Research Institute, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104, and Hirohashi Cell Configuration Project, ERATO, Japan Scientific and Technology Corporation, Tsukuba Research Consortium, 9-4, Tokodai 5-chome, Tsukuba 300-26, Japan
Abstract
It has long been known that cell-cell adhesiveness is
generally reduced in human cancers. Tumor cells are dissociated
throughout the entire tumor masses of diffuse-type cancers,
whereas those of solid tumors with high metastatic potentials are often
focally dissociated or dedifferentiated at the invading fronts.
Thus, both irreversible and reversible mechanisms for
inactivating the cell adhesion system appear to exist. This paper
focuses on the cadherin system, which mediates
Ca2+-dependent homophilic cell-cell adhesion. The E
(epithelial)-cadherin-mediated cell adhesion system in cancer cells is
inactivated by multiple mechanisms corresponding to the pathological
features described above. Mutations have been found in the genes for
E-cadherin and its undercoat proteins,
- and
ß-catenins, which connect cadherins to actin filaments and
establish firm cell-cell adhesion. Transcriptional inactivation of
E-cadherin expression was shown to occur frequently in tumor
progression. E-cadherin expression in human cancer cells is regulated
by CpG methylation around the promoter region. The cadherin
system interacts directly with products of oncogenes,
eg, c-erbB-2 protein and the epidermal
growth factor receptor, and of the tumor suppressor
gene, adenomatous polyposis coli (APC) protein, through
ß-catenin, which may be important in signal transduction
pathways contributing to the determination of the biological properties
of human cancers. In conclusion, inactivation of the E-cadherin
system by multiple mechanisms, including both genetic and
epigenetic events, plays a significant role in multistage
carcinogenesis.
This article has been cited by other articles:
![]() |
T. Goto, A. Ishizaka, M. Katayama, M. Kohno, S. Tasaka, S. Fujishima, K. Kobayashi, and H. Nomori Involvement of E-cadherin cleavage in reperfusion injury Eur. J. Cardiothorac. Surg., February 1, 2010; 37(2): 426 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kariya, C. Kawamura, T. Tabei, and J. Gu Bisecting GlcNAc Residues on Laminin-332 Down-regulate Galectin-3-dependent Keratinocyte Motility J. Biol. Chem., January 29, 2010; 285(5): 3330 - 3340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deplazes, M. Fuchs, S. Rauser, H. Genth, E. Lengyel, R. Busch, and B. Luber Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation Hum. Mol. Genet., October 1, 2009; 18(19): 3632 - 3644. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Knirsh, I. Ben-Dror, B. Spangler, G. D. Matthews, S. Kuphal, A. K. Bosserhoff, and L. Vardimon Loss of E-Cadherin-mediated Cell-Cell Contacts Activates a Novel Mechanism for Up-Regulation of the Proto-Oncogene c-Jun Mol. Biol. Cell, April 1, 2009; 20(7): 2121 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Park, O. S. Kim, S.-M. Yun, S. A. Jo, I. Jo, and Y. H. Koh Presenilin 1/{gamma}-Secretase Is Associated with Cadmium-Induced E-Cadherin Cleavage and COX-2 Gene Expression in T47D Breast Cancer Cells Toxicol. Sci., December 1, 2008; 106(2): 413 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Helguero, K. Lindberg, C. Gardmo, T. Schwend, J.-A. Gustafsson, and L.-A. Haldosen Different Roles of Estrogen Receptors {alpha} and {beta} in the Regulation of E-Cadherin Protein Levels in a Mouse Mammary Epithelial Cell Line Cancer Res., November 1, 2008; 68(21): 8695 - 8704. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Onder, P. B. Gupta, S. A. Mani, J. Yang, E. S. Lander, and R. A. Weinberg Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways Cancer Res., May 15, 2008; 68(10): 3645 - 3654. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Y. Wang, C.-Q. Lu, R.-M. Zhang, X.-H. Hu, and Z. W. Luo The E-cadherin Gene Polymorphism 160C->A and Cancer Risk: A HuGE Review and Meta-Analysis of 26 Case-Control Studies Am. J. Epidemiol., January 1, 2008; 167(1): 7 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Graham, M. D. Pope, T. Rimchala, B. K. Huang, and A. R. Asthagiri A Microtiter Assay for Quantifying Protein-Protein Interactions Associated with Cell-Cell Adhesion J Biomol Screen, August 1, 2007; 12(5): 683 - 693. [Abstract] [PDF] |
||||
![]() |
L. H. El Touny and P. P. Banerjee Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype Carcinogenesis, August 1, 2007; 28(8): 1710 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ezaki, R.-J. Guo, H. Li, A. B. Reynolds, and J. P. Lynch The homeodomain transcription factors Cdx1 and Cdx2 induce E-cadherin adhesion activity by reducing beta- and p120-catenin tyrosine phosphorylation Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G54 - G65. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lorch, T. O. Thomas, and H.-J. Schmoll Bortezomib Inhibits Cell-Cell Adhesion and Cell Migration and Enhances Epidermal Growth Factor Receptor Inhibitor-Induced Cell Death in Squamous Cell Cancer Cancer Res., January 15, 2007; 67(2): 727 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takkunen, R. Grenman, M. Hukkanen, M. Korhonen, A. Garcia de Herreros, and I. Virtanen Snail-dependent and -independent Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Cells J. Histochem. Cytochem., November 1, 2006; 54(11): 1263 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rahnama, F. Shafiei, P. D. Gluckman, M. D. Mitchell, and P. E. Lobie Epigenetic Regulation of Human Trophoblastic Cell Migration and Invasion Endocrinology, November 1, 2006; 147(11): 5275 - 5283. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, T. Nakagawa, S. Itoh, K.-i. Inamori, T. Isaji, Y. Kariya, A. Kondo, E. Miyoshi, K. Miyazaki, N. Kawasaki, et al. N-Acetylglucosaminyltransferase III Antagonizes the Effect of N-Acetylglucosaminyltransferase V on {alpha}3beta1 Integrin-mediated Cell Migration J. Biol. Chem., October 27, 2006; 281(43): 32122 - 32130. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Lee, K. Man, R. T.P. Poon, C. M. Lo, A. P. Yuen, I. O. Ng, K. T. Ng, W. Leonard, and S. T. Fan Signal Transducers and Activators of Transcription 5b Activation Enhances Hepatocellular Carcinoma Aggressiveness through Induction of Epithelial-Mesenchymal Transition. Cancer Res., October 15, 2006; 66(20): 9948 - 9956. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Lee, R. T.P. Poon, A. P. Yuen, M. T. Ling, W. K. Kwok, X. H. Wang, Y. C. Wong, X. Y. Guan, K. Man, K. L. Chau, et al. Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition. Clin. Cancer Res., September 15, 2006; 12(18): 5369 - 5376. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Munday, M. M. Brennan, and M. Kiupel Altered Expression of {beta}-catenin, E-cadherin, Cycloxygenase-2, and p53 Protein by Ovine Intestinal Adenocarcinoma Cells Veterinary Pathology, September 1, 2006; 43(5): 613 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Hosaka, T Ryu, W Cui, Q Li, A Nishida, T Miyake, T Takaki, M Inaba, and S Ikehara Relationship of p53, Bcl-2, Ki-67 index and E-cadherin expression in early invasive breast cancers with comedonecrosis as an accelerated apoptosis J. Clin. Pathol., July 1, 2006; 59(7): 692 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-X. Yan, W. Yang, R. Zhang, L. Chen, L. Tang, B. Zhai, S.-Q. Liu, H.-F. Cao, X.-B. Man, H.-P. Wu, et al. Protein-tyrosine Phosphatase PCP-2 Inhibits beta-Catenin Signaling and Increases E-cadherin-dependent Cell Adhesion J. Biol. Chem., June 2, 2006; 281(22): 15423 - 15433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Worsham, K. M. Chen, V. Meduri, A. O. H. Nygren, A. Errami, J. P. Schouten, and M. S. Benninger Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, June 1, 2006; 132(6): 668 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Liu, C. M. Nelson, D. M. Pirone, and C. S. Chen E-cadherin engagement stimulates proliferation via Rac1 J. Cell Biol., May 8, 2006; 173(3): 431 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-J. Liu, M. Xiao, K. Balint, K. S.M. Smalley, P. Brafford, R. Qiu, C. C. Pinnix, X. Li, and M. Herlyn Notch1 Signaling Promotes Primary Melanoma Progression by Activating Mitogen-Activated Protein Kinase/Phosphatidylinositol 3-Kinase-Akt Pathways and Up-regulating N-Cadherin Expression. Cancer Res., April 15, 2006; 66(8): 4182 - 4190. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Kanczuga-Koda, S Sulkowski, A Lenczewski, M Koda, A Wincewicz, M Baltaziak, and M Sulkowska Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J. Clin. Pathol., April 1, 2006; 59(4): 429 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashida, K. Honda, M. Idogawa, Y. Ino, M. Ono, A. Tsuchida, T. Aoki, S. Hirohashi, and T. Yamada E-Cadherin Regulates the Association between {beta}-Catenin and Actinin-4 Cancer Res., October 1, 2005; 65(19): 8836 - 8845. [Abstract] [Full Text] [PDF] |
||||
![]() |
W-B Zhong, Y-C Liang, C-Y Wang, T-C Chang, and W-S Lee Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling Endocr. Relat. Cancer, September 1, 2005; 12(3): 615 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Motti, D. Califano, G. Baldassarre, A. Celetti, F. Merolla, F. Forzati, M. Napolitano, B. Tavernise, A. Fusco, and G. Viglietto Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas Carcinogenesis, June 1, 2005; 26(6): 1021 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Yao, J. F. Tseng, S. Worah, K. R. Hess, P. F. Mansfield, C. H. Crane, I. I. Schnirer, S. Reddy, S. S. Chiang, A. Najam, et al. Clinicopathologic Behavior of Gastric Adenocarcinoma in Hispanic Patients: Analysis of a Single Institution's Experience Over 15 Years J. Clin. Oncol., May 1, 2005; 23(13): 3094 - 3103. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S.M. Smalley, P. Brafford, N. K. Haass, J. M. Brandner, E. Brown, and M. Herlyn Up-Regulated Expression of Zonula Occludens Protein-1 in Human Melanoma Associates with N-Cadherin and Contributes to Invasion and Adhesion Am. J. Pathol., May 1, 2005; 166(5): 1541 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W Stoker Protein tyrosine phosphatases and signalling J. Endocrinol., April 1, 2005; 185(1): 19 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Uchikado, S. Natsugoe, H. Okumura, T. Setoyama, M. Matsumoto, S. Ishigami, and T. Aikou Slug Expression in the E-cadherin Preserved Tumors Is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma Clin. Cancer Res., February 1, 2005; 11(3): 1174 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Bachelder, S.-O. Yoon, C. Franci, A. G. de Herreros, and A. M. Mercurio Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition J. Cell Biol., January 3, 2005; 168(1): 29 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Miotto, S. Sabbioni, A. Veronese, G. A. Calin, S. Gullini, A. Liboni, L. Gramantieri, L. Bolondi, E. Ferrazzi, R. Gafa, et al. Frequent Aberrant Methylation of the CDH4 Gene Promoter in Human Colorectal and Gastric Cancer Cancer Res., November 15, 2004; 64(22): 8156 - 8159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsutsumi, T. Yanagawa, T. Shimura, H. Kuwano, and A. Raz Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis Clin. Cancer Res., November 15, 2004; 10(22): 7775 - 7784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mukhina, H. C. Mertani, K. Guo, K.-O. Lee, P. D. Gluckman, and P. E. Lobie From The Cover: Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone PNAS, October 19, 2004; 101(42): 15166 - 15171. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Faleiro-Rodrigues, I. Macedo-Pinto, D. Pereira, and C. S. Lopes Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas Ann. Onc., October 1, 2004; 15(10): 1535 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Marchong, D. Chen, T. W. Corson, C. Lee, M. Harmandayan, E. Bowles, N. Chen, and B. L. Gallie Minimal 16q Genomic Loss Implicates Cadherin-11 in Retinoblastoma Mol. Cancer Res., September 1, 2004; 2(9): 495 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lorch, J. Klessner, J. K. Park, S. Getsios, Y. L. Wu, M. S. Stack, and K. J. Green Epidermal Growth Factor Receptor Inhibition Promotes Desmosome Assembly and Strengthens Intercellular Adhesion in Squamous Cell Carcinoma Cells J. Biol. Chem., August 27, 2004; 279(35): 37191 - 37200. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kudo, S. Kitajima, I. Ogawa, M. Hiraoka, S. Sargolzaei, M. R. Keikhaee, S. Sato, M. Miyauchi, and T. Takata Invasion and Metastasis of Oral Cancer Cells Require Methylation of E-Cadherin and/or Degradation of Membranous {beta}-Catenin Clin. Cancer Res., August 15, 2004; 10(16): 5455 - 5463. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shibata, A. Kokubu, S. Sekine, Y. Kanai, and S. Hirohashi Cytoplasmic p120ctn Regulates the Invasive Phenotypes of E-Cadherin-Deficient Breast Cancer Am. J. Pathol., June 1, 2004; 164(6): 2269 - 2278. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Maruya, J.-P. J. Issa, R. S. Weber, D. I. Rosenthal, J. C. Haviland, R. Lotan, and A. K. El-Naggar Differential Methylation Status of Tumor-Associated Genes in Head and Neck Squamous Carcinoma: Incidence and Potential Implications Clin. Cancer Res., June 1, 2004; 10(11): 3825 - 3830. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimada, S. Yamasaki, Y. Hashimoto, T. Ito, J.-i. Kawamura, T. Soma, Y. Ino, Y. Nakanishi, M. Sakamoto, S. Hirohashi, et al. Clinical Significance of Dysadherin Expression in Gastric Cancer Patients Clin. Cancer Res., April 15, 2004; 10(8): 2818 - 2823. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hiendlmeyer, S. Regus, S. Wassermann, F. Hlubek, A. Haynl, A. Dimmler, C. Koch, C. Knoll, M. van Beest, U. Reuning, et al. {beta}-Catenin Up-Regulates the Expression of the Urokinase Plasminogen Activator in Human Colorectal Tumors Cancer Res., February 15, 2004; 64(4): 1209 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Etoh, Y. Kanai, S. Ushijima, T. Nakagawa, Y. Nakanishi, M. Sasako, S. Kitano, and S. Hirohashi Increased DNA Methyltransferase 1 (DNMT1) Protein Expression Correlates Significantly with Poorer Tumor Differentiation and Frequent DNA Hypermethylation of Multiple CpG Islands in Gastric Cancers Am. J. Pathol., February 1, 2004; 164(2): 689 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-B. Guo, I. Lee, M. Kamar, and M. Pierce N-Acetylglucosaminyltransferase V Expression Levels Regulate Cadherin-associated Homotypic Cell-Cell Adhesion and Intracellular Signaling Pathways J. Biol. Chem., December 26, 2003; 278(52): 52412 - 52424. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kremer, L. Quintanilla-Martinez, M. Fuchs, A. Gamboa-Dominguez, S. Haye, H. Kalthoff, E. Rosivatz, C. Hermannstadter, R. Busch, H. Hofler, et al. Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis Carcinogenesis, December 1, 2003; 24(12): 1879 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Conacci-Sorrell, I. Simcha, T. Ben-Yedidia, J. Blechman, P. Savagner, and A. Ben-Ze'ev Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of {beta}-catenin signaling, Slug, and MAPK J. Cell Biol., November 24, 2003; 163(4): 847 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Xiao, D. F. Allison, K. M. Buckley, M. D. Kottke, P. A. Vincent, V. Faundez, and A. P. Kowalczyk Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells J. Cell Biol., November 10, 2003; 163(3): 535 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, Y. Shimada, Y. Hashimoto, J. Kaganoi, T. Kan, G. Watanabe, Y. Murakami, and M. Imamura Involvement of TSLC1 in Progression of Esophageal Squamous Cell Carcinoma Cancer Res., October 1, 2003; 63(19): 6320 - 6326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishimura, T. Saito, H. Yamasaki, and R. Kudo Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells Carcinogenesis, October 1, 2003; 24(10): 1615 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wen, T. C. Caffrey, M. J. Wheelock, K. R. Johnson, and M. A. Hollingsworth Nuclear Association of the Cytoplasmic Tail of MUC1 and {beta}-Catenin J. Biol. Chem., September 26, 2003; 278(39): 38029 - 38039. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sato, Y. Ino, A. Miura, Y. Abe, H. Sakai, K. Ito, and S. Hirohashi Dysadherin: Expression and Clinical Significance in Thyroid Carcinoma J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4407 - 4412. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nawrocki-Raby, C. Gilles, M. Polette, C. Martinella-Catusse, N. Bonnet, E. Puchelle, J.-M. Foidart, F. van Roy, and P. Birembaut E-Cadherin Mediates MMP Down-Regulation in Highly Invasive Bronchial Tumor Cells Am. J. Pathol., August 1, 2003; 163(2): 653 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsuiji, S. Takasaki, M. Sakamoto, T. Irimura, and S. Hirohashi Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion Glycobiology, July 1, 2003; 13(7): 521 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sugimachi, S. Tanaka, T. Kameyama, K.-i. Taguchi, S.-i. Aishima, M. Shimada, K. Sugimachi, and M. Tsuneyoshi Transcriptional Repressor Snail and Progression of Human Hepatocellular Carcinoma Clin. Cancer Res., July 1, 2003; 9(7): 2657 - 2664. [Abstract] [Full Text] [PDF] |
||||
![]() |
A O-O Chan, S-K Lam, B C-Y Wong, W-M Wong, M-F Yuen, Y-H Yeung, W-M Hui, A Rashid, and Y-L Kwong Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer Gut, April 1, 2003; 52(4): 502 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimamura, M. Sakamoto, Y. Ino, Y. Sato, K. Shimada, T. Kosuge, H. Sekihara, and S. Hirohashi Dysadherin Overexpression in Pancreatic Ductal Adenocarcinoma Reflects Tumor Aggressiveness: Relationship to E-Cadherin Expression J. Clin. Oncol., February 15, 2003; 21(4): 659 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Birrer, D. Birrer, and J. V. Klavins Hepatocellular Carcinoma and Hepatitis Virus Ann. Clin. Lab. Sci., January 1, 2003; 33(1): 39 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rosivatz, I. Becker, K. Specht, E. Fricke, B. Luber, R. Busch, H. Hofler, and K.-F. Becker Differential Expression of the Epithelial-Mesenchymal Transition Regulators Snail, SIP1, and Twist in Gastric Cancer Am. J. Pathol., November 1, 2002; 161(5): 1881 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Le, S. R. Joseph, A. S. Yap, and J. L. Stow Protein kinase C regulates endocytosis and recycling of E-cadherin Am J Physiol Cell Physiol, August 1, 2002; 283(2): C489 - C499. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-N. Tsai, C.-L. Tsai, K.-P. Tse, H.-Y. Chang, and Y.-S. Chang The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases PNAS, July 23, 2002; 99(15): 10084 - 10089. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Nam, Y. Ino, M. Sakamoto, and S. Hirohashi Src Family Kinase Inhibitor PP2 Restores the E-Cadherin/Catenin Cell Adhesion System in Human Cancer Cells and Reduces Cancer Metastasis Clin. Cancer Res., July 1, 2002; 8(7): 2430 - 2436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Weng, M. Xin, L. Pablo, D. Grueneberg, M. Hagel, G. Bain, T. Muller, and J. Papkoff Protection against Anoikis and Down-regulation of Cadherin Expression by a Regulatable beta -Catenin Protein J. Biol. Chem., May 17, 2002; 277(21): 18677 - 18686. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakanishi, M. Sakamoto, J. Yasuda, M. Takamura, N. Fujita, T. Tsuruo, S. Todo, and S. Hirohashi Critical Involvement of the Phosphatidylinositol 3-Kinase/Akt Pathway in Anchorage-independent Growth and Hematogeneous Intrahepatic Metastasis of Liver Cancer Cancer Res., May 1, 2002; 62(10): 2971 - 2975. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. C. S. Wong and M. Pignatelli {beta}-Catenin--A Linchpin in Colorectal Carcinogenesis? Am. J. Pathol., February 1, 2002; 160(2): 389 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, K. Satyamoorthy, and M. Herlyn DYNAMICS OF CELL INTERACTIONS AND COMMUNICATIONS DURING MELANOMA DEVELOPMENT Critical Reviews in Oral Biology & Medicine, January 1, 2002; 13(1): 62 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, Y. Oda, K. Sugimachi, K.-i. Kawaguchi, S. Tamiya, K. Tanaka, S. Matsuda, A. Sakamoto, Y. Iwamoto, and M. Tsuneyoshi E-Cadherin Gene Mutations Frequently Occur in Synovial Sarcoma as a Determinant of Histological Features Am. J. Pathol., December 1, 2001; 159(6): 2117 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jung, M. Schrauder, U. Oswald, C. Knoll, P. Sellberg, R. Palmqvist, G. Niedobitek, T. Brabletz, and T. Kirchner The Invasion Front of Human Colorectal Adenocarcinomas Shows Co-Localization of Nuclear {beta}-Catenin, Cyclin D1, and p16INK4A and Is a Region of Low Proliferation Am. J. Pathol., November 1, 2001; 159(5): 1613 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Brabletz, A. Jung, S. Reu, M. Porzner, F. Hlubek, L. A. Kunz-Schughart, R. Knuechel, and T. Kirchner Variable beta -catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment PNAS, August 28, 2001; 98(18): 10356 - 10361. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prokhortchouk, B. Hendrich, H. Jorgensen, A. Ruzov, M. Wilm, G. Georgiev, A. Bird, and E. Prokhortchouk The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor Genes & Dev., July 1, 2001; 15(13): 1613 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. O. Toyooka, S. Toyooka, A. K. Virmani, U. G. Sathyanarayana, D. M. Euhus, M. Gilcrease, J. D. Minna, and A. F. Gazdar Loss of Expression and Aberrant Methylation of the CDH13 (H-Cadherin) Gene in Breast and Lung Carcinomas Cancer Res., June 1, 2001; 61(11): 4556 - 4560. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Menke, C. Philippi, R. Vogelmann, B. Seidel, M. P. Lutz, G. Adler, and D. Wedlich Down-Regulation of E-Cadherin Gene Expression by Collagen Type I and Type III in Pancreatic Cancer Cell Lines Cancer Res., April 1, 2001; 61(8): 3508 - 3517. [Abstract] [Full Text] |
||||
![]() |
Y. Naishiro, T. Yamada, A. S. Takaoka, R. Hayashi, F. Hasegawa, K. Imai, and S. Hirohashi Restoration of Epithelial Cell Polarity in a Colorectal Cancer Cell Line by Suppression of {beta}-catenin/T-Cell Factor 4-mediated Gene Transactivation Cancer Res., March 1, 2001; 61(6): 2751 - 2758. [Abstract] [Full Text] |
||||
![]() |
C. A. Blum, M. Xu, G. A. Orner, A. T. Fong, G. S. Bailey, G. D. Stoner, D. T. Horio, and R. H. Dashwood {beta}-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol Carcinogenesis, February 1, 2001; 22(2): 315 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Fearon BRCA1 and E-Cadherin Promoter Hypermethylation and Gene Inactivation in Cancer--Association or Mechanism? J Natl Cancer Inst, April 5, 2000; 92(7): 515 - 517. [Full Text] [PDF] |
||||
![]() |
G. Tamura, J. Yin, S. Wang, A. S. Fleisher, T. Zou, J. M. Abraham, D. Kong, K. N. Smolinski, K. T. Wilson, S. P. James, et al. E-Cadherin Gene Promoter Hypermethylation in Primary Human Gastric Carcinomas J Natl Cancer Inst, April 5, 2000; 92(7): 569 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huang, B. M. Mahler-Araujo, A. Sankila, L. Chimelli, Y. Yonekawa, P. Kleihues, and H. Ohgaki APC Mutations in Sporadic Medulloblastomas Am. J. Pathol., February 1, 2000; 156(2): 433 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huang, H. Fujii, A. Sankila, B. M. Mahler-Araujo, M. Matsuda, G. Cathomas, and H. Ohgaki {beta}-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection Am. J. Pathol., December 1, 1999; 155(6): 1795 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-F. Becker, E. Kremmer, M. Eulitz, I. Becker, G. Handschuh, C. Schuhmacher, W. Muller, H. E. Gabbert, A. Ochiai, S. Hirohashi, et al. Analysis of E-Cadherin in Diffuse-Type Gastric Cancer Using a Mutation-Specific Monoclonal Antibody Am. J. Pathol., December 1, 1999; 155(6): 1803 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gamallo, J. Palacios, G. Moreno, J. Calvo de Mora, A. Suarez, and A. Armas {beta}-Catenin Expression Pattern in Stage I and II Ovarian Carcinomas : Relationship with {beta}-Catenin Gene Mutations,Clinicopathological Features, and Clinical Outcome Am. J. Pathol., August 1, 1999; 155(2): 527 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Maeno, S. Moroi, H. Nagashima, T. Noda, H. Shiozaki, M. Monden, S. Tsukita, and A. Nagafuchi {alpha}-Catenin-Deficient F9 Cells Differentiate into Signet Ring Cells Am. J. Pathol., May 1, 1999; 154(5): 1323 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Efstathiou and M. Pignatelli Modulation of Epithelial Cell Adhesion in Gastrointestinal Homeostasis Am. J. Pathol., August 1, 1998; 153(2): 341 - 347. [Full Text] [PDF] |
||||
![]() |
A. L. Giannini, M. d. M. Vivanco, and R. M. Kypta alpha -Catenin Inhibits beta -Catenin Signaling by Preventing Formation of a beta -Catenin{middle dot}T-cell Factor{middle dot}DNA Complex J. Biol. Chem., July 14, 2000; 275(29): 21883 - 21888. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Poser, D. Dominguez, A. G. de Herreros, A. Varnai, R. Buettner, and A. K Bosserhoff Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor Snail J. Biol. Chem., June 29, 2001; 276(27): 24661 - 24666. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ino, M. Gotoh, M. Sakamoto, K. Tsukagoshi, and S. Hirohashi Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis PNAS, January 8, 2002; 99(1): 365 - 370. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |